Pharma dealmaking boosts M&A to record-setting heights in Q1

No surprise that the health industry is setting records, M&A-wise. According to PricewaterhouseCoopers, life sciences companies inked 35 deals worth $166.3 billion in Q1--more than all of 2014's transactions combined. That's because of some high-value offers, including AbbVie's ($ABBV) $21 billion bid to buy Pharmacyclics ($PCYC). Report